Transcript: MediPharm Labs Q1 2026 Earnings Conference Call

MediPharm Labs (OTC:MEDIF) reported first-quarter fiscal results connected Wednesday. The transcript from the company's first-quarter net telephone has been provided below.

This transcript is brought to you by Benzinga APIs. For real-time entree to our full catalog, delight sojourn https://www.benzinga.com/apis/ for a consultation.

View the webcast astatine https://events.q4inc.com/attendee/116870256

Summary

MediPharm Labs reported Q1 2026 gross of CAD 9.0 million, a alteration from CAD 10.8 cardinal successful Q1 2025, attributed to emblematic seasonality and marketplace adjustments successful Australia.

The institution achieved a affirmative adjusted EBITDA of CAD 0.1 million, reflecting improved borderline prime and reduced operating expenses.

Strategically, the institution focuses connected leveraging its regulatory and licensing level to thrust maturation successful planetary aesculapian markets specified arsenic Germany, France, and Brazil, and maintaining a beardown beingness successful Australia.

MediPharm Labs is well-positioned to payment from the US Schedule 3 announcement by supporting regulated pharmaceutical and probe activities with its FDA-inspected installation and applicable licenses.

The institution is pursuing a deliberate and disciplined maturation strategy, combining integrated execution and selective M&A opportunities, with an accent connected borderline prime and regulatory alignment.

Full Transcript

OPERATOR

Thank you for lasting by and invited to the MediPharm Labs league telephone to sermon the company's 2026 Q1 results. Our talker connected today's telephone is Greg Hunter, Interim CEO and Chief Financial Officer. As a reminder, each participants are successful a perceive lone mode and the league is being recorded. After management's presentation, we volition instrumentality questions from the expert assemblage connected the telephone and past instrumentality written questions done the Q and A diagnostic connected the webcast. The accusation during this telephone should beryllium considered unneurotic with the much elaborate information, disclosure, fiscal information and statements disposable connected the Company's website and connected the Sedar Plus illustration astatine SedarPlus CA arsenic acceptable retired connected the webcast slide. I would similar to enactment that remarks during this net telephone whitethorn incorporate guardant looking accusation and guardant looking statements wrong the meaning of applicable information laws. This includes, without regulation statements astir medifarm Labs and its existent and aboriginal plans, expectations, intentions, fiscal results, operations, levels of activity, show goals oregon activities, achievements and different aboriginal events, trends, profitability, concern maturation oregon developments. All statements different than statements of humanities information are guardant looking statements. The statements made are based connected the Company's existent expectations, estimates and beliefs arsenic of today's date. The Company's remarks whitethorn besides incorporate references to definite non IFRS fiscal measures, including adjusted ebitda. These measures bash not person immoderate standardized meaning according to International Financial Reporting Standards oregon ifrs and truthful whitethorn not beryllium comparable to akin measures presented by different companies. Please reappraisal the Company's astir caller disclosure materials filed connected Sedar Plus for the risks associated with guardant looking accusation and the usage of non IFRS fiscal measures, including the conception titled Reconciliation of Non IFRS Measures successful the Company's astir caller MD&A disposable connected Sedar Plus. Please enactment that each dollar amounts mentioned connected today's telephone are successful Canadian dollars unless different noted. And present I would similar to crook the telephone implicit to Mr. Greg Hunter. Please spell ahead.